Attached files

file filename
EX-99.1 - PRESS RELEASE - PURADYN FILTER TECHNOLOGIES INCpfti_ex99z1.htm


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)   November 2, 2015


PURADYN FILTER TECHNOLOGIES INCORPORATED

(Exact name of registrant as specified in its charter)


Delaware

001-11991

14-1708544

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)


2017 High Ridge Road, Boynton Beach, FL

33426

(Address of principal executive offices)

(Zip Code)


Registrant's telephone number, including area code

(561) 547-9499


not applicable

(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 






Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On November 2, 2015, Puradyn Filter Technologies Incorporated (the “Company”) was notified of the death of Dr. Charles W. Walton.  Dr. Walton had been a member of the Company's board of directors since August 2005 and served as a member of the Audit Committee.

 

Item 7.01

Regulation FD Disclosure.

 

On November 3, 2015, the Company issued a press release, which is attached as Exhibit 99.1 hereto, announcing the death of Dr. Walton.  A copy of this press release is included as Exhibit 99.1 to this report.

 

Pursuant to General Instruction B.2 of Form 8-K, the information in this Item 7.01 of Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise be subject to the liabilities of that section, nor is it incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

Item 9.01

Financial Statements and Exhibits.


(d)

Exhibits


Exhibit No.

 

Description

99.1

          

Press release dated November 3, 2015











2



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

PURADYN FILTER TECHNOLOGIES INCORPORATED

 

 

 

Date:  November 3, 2015

By:

/s/ Alan J. Sandler

 

 

Alan J. Sandler,

Principal Financial Officer and Vice President










3